Accumulating evidence indicates that tumor‐derived factors downregulate NKp30, NKp46, and NKG2D expression, resulting in diminished cytotoxic activity of NK cells against tumors and contributing to NK cell senescence. This evidence concerns the gene NCR1 and neoplasm.